INDIA PHARMA INDUSTRY SOUNDS GENERICS WARNING OVER EU TRADE DEAL
March 1st, 2011 BY KEITH NUTHALL THE EUROPEAN Union (EU) is running into opposition from the Indian pharmaceutical industry by pushing for a data exclusivity clause to be written into a planned EU-India free trade agreement. The rule would prevent Indian generic drugs manufacturers from developing generics while medicines are under patent protection, slowing their release of drugs once this expires. Protests have been staged in Indian cities against the deal, including HIV patient groups, focusing on claims that the agreement would restrict their access to affordable medicines. ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.